ROVAC CORP
10QSB, EX-27, 2000-12-13
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: ROVAC CORP, 10QSB, 2000-12-13
Next: SEAGRAM CO LTD, 8-K, 2000-12-13



<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          JUL-31-2000
<PERIOD-END>                               OCT-31-2000
<CASH>                                         (1,981)
<SECURITIES>                                         0
<RECEIVABLES>                                   77,144
<ALLOWANCES>                                         0
<INVENTORY>                                      8,427
<CURRENT-ASSETS>                                85,571
<PP&E>                                         132,568
<DEPRECIATION>                               (126,959)
<TOTAL-ASSETS>                                 162,562
<CURRENT-LIABILITIES>                        2,750,633
<BONDS>                                              0
                                0
                                  1,200,000
<COMMON>                                       399,581
<OTHER-SE>                                 (4,187,652)
<TOTAL-LIABILITY-AND-EQUITY>                   162,562
<SALES>                                            182
<TOTAL-REVENUES>                                26,713
<CGS>                                            3,811
<TOTAL-COSTS>                                   37,975
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                            (20,118)
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (31,380)
<EPS-BASIC>                                     (0.00)
<EPS-DILUTED>                                        0


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission